Kenvue Sees 2025 Profit Below Estimates as Strong Dollar, Weak Cough Product Sales Hit
The company forecast flat to 2% growth in 2025 per share adjusted profit, compared with $1.14 it earned in 2024. Analysts ...
Kenvue Sales Miss Estimates as Weak Volumes Plague Tylenol Maker
Aid, reported sales that missed analyst estimates after weaker-than-expected volumes hurt results and provided activist ...
Kenvue says ‘committed’ to acting in best interests of company, shareholders
Kenvue (KVUE) issued the following statement in response to Starboard Value’s submission of four nominees to stand for election to the Kenvue ...
Starboard pushes medical device maker Becton Dickinson to spin off unit
Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the $72bn medical technology company to sell its life sciences division, according to people familiar with the ...
FiercePharma10d
Pfizer avoids board nominations from Starboard as proxy fight rolls on: Bloomberg
More recently, Starboard reportedly took up a “sizeable stake” in Johnson & Johnson’s consumer health spinout Kenvue ...
Benzinga.com20d
Kenvue (NYSE:KVUE) Stock Quotes, Forecast and News Summary
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake ... Vandana Singh Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty ...
Starboard Value nominates four directors to Kenvue board
Hedge fund Starboard Value has nominated four directors for positions on the board of consumer products company Kenvue (NYSE: KVUE), according to a regulatory fil ...